Biolife solutions stock.

BLFS BioLife Solutions stock chart. #fintwits #money #wallstreet #stockmarket #stocks. 0 points. 1 comment. 1. 0 comments. share. save. 2. Posted by 2 years ago. I want to buy a trading bot, any recommendations here? 2. 3 comments. share. save. 1. Posted by 2 years ago. Adam Khoo FX trading. Hello! I got some courses a while back and have ...

Biolife solutions stock. Things To Know About Biolife solutions stock.

BioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to de-risk biologic manufacturing, storage, distribution, and transportation in the cell and gene therapy (CGT) industry and broader biopharma markets.2.70% of BioLife Solutions stock is owned by insiders. Learn more on BLFS's insider holdings. Which BioLife Solutions insiders have been buying company stock? The following insider purchased BLFS shares in the last 24 months: Casdin Partners Master Fund, L ($12,648,274.13).BioLife Solutions Company Stats. As of December 2020. Industry Health Care Equipment & Services. ... BioLife Solutions (BLFS) Stock Key Data. Summary Additional Data …Get the latest BioLife Solutions, Inc. (BLFS) stock news and headlines to help you in your trading and investing decisions.Jun 26, 2020 · Hedge fund activity in BioLife Solutions, Inc. (NASDAQ:BLFS) Heading into the second quarter of 2020, a total of 9 of the hedge funds tracked by Insider Monkey were long this stock, a change of ...

The BioLife Solutions stock price gained 3.76% on the last trading day (Friday, 24th Nov 2023), rising from $13.57 to $14.08. During the last trading day the stock fluctuated 11.10% from a day low at $12.79 to a day high of $14.21. The price has risen in 6 of the last 10 days and is up by 23.62% over the past 2 weeks.Aug 8, 2023 · BioLife Solutions is updating 2023 revenue guidance, which is based on expectations for its existing business. Total revenue for 2023 is expected to range from $144 million to $158 million ... Cold Chain Solutions. Cold Chain Shippers. ... Stock. CONTACT. BioLife Solutions Inc. 3303 Monte Villa Parkway, Suite 310, Bothell, WA 98021 USA ...

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BLFS is experiencing ...

Register here to receive email notifications with updates about our press releases, stock price, SEC filings and more. Presentations & Webcasts. Investor Presentation. ... BioLife Solutions Inc. 3303 Monte Villa Parkway, Suite 310, Bothell, WA 98021 USA. T +1.866.424.6543 or 425.402.1400 F +1.425.402.1433 E …Mar 13, 2023 · BioLife Solutions, Inc. (BLFS) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the ... Jan 5, 2023 · First, BioLife Solutions, Inc. stock is trading at 1.95x book value of equity, which may or may not represent a value proposition. However, it should also be noted the breakdown of its book value ... Home Contact our Service Support Team here evo® Cold Chain Product Support Contact For immediate assistance, please enter a support ticket using the contact link above. Stirling Ultracold® Product Support For immediate assistance, please call us Monday through Friday (8:00 am to 5:00 pm EST) at: Service Phone: +1.740.274.7980 Email: …

The estimated net worth of Roderick de Greef is at least $463,582.14 as of November 30th, 2022. Mr. de Greef owns 34,314 shares of BioLife Solutions stock worth more than $463,582 as of November 20th. This net worth estimate does not reflect any other investments that Mr. de Greef may own.

This is a signal that BLFS's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

On December 15, 2022, BioLife Solutions, Inc. (NASDAQ:BLFS) stock closed at $18.77 per share. One-month return of BioLife Solutions, Inc. (NASDAQ:BLFS) was -11.46%, and its shares lost 48.63% of ...Evogene Ltd. -0.32%. $32.76M. BLFS | Complete BioLife Solutions Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.The BioLife Solutions stock price fell by -1.88% on the last day (Wednesday, 29th Nov 2023) from $12.75 to $12.51.It has now fallen 3 days in a row. During the last trading day the stock fluctuated 9.31% from a day low at $12.46 to a day high of $13.62.The price has been going up and down for this period, and there has been a …Cell Thawing and Transport System for Optimal Thaw Rate. The ThawSTAR CFT2 Cell Thawing System accommodates a 1.8 – 2.0 mL cryogenic vial. The ThawSTAR CFT1.5 Cell Thawing System accommodates a 1.5 mL cryogenic vial. ThawSTAR AT6 Transport and Thawing System for AT-Closed Vial improves the overall handling of biosamples by …Company profile page for BioLife Solutions Inc including stock price, company news, executives, board members, and contact informationBioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2023 Earnings Call Transcript November 9, 2023 BioLife Solutions, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.38. Operator: Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to the BioLife Solutions Third Quarter 2023 Shareholder and Analyst ...

Sep 1, 2021 · BOTHELL, Wash., Sept. 1, 2021 / PRNewswire / -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that it has closed its acquisition of Sexton Biotechnologies ... BioLife Solutions, Inc. announced that it has received $10.374976 million in funding from Casdin Capital, LLC. 10-19. CI. Lake Street Adjusts Price Target on BioLife Solutions to …On December 15, 2022, BioLife Solutions, Inc. (NASDAQ:BLFS) stock closed at $18.77 per share. One-month return of BioLife Solutions, Inc. (NASDAQ:BLFS) was -11.46%, and its shares lost 48.63% of ...In today’s fast-paced world, maintaining a healthy lifestyle can be challenging. However, thanks to technological advancements, we now have access to various tools and applications that can help us track our nutritional intake and make info...Track Biolife Solutions Inc (BLFS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsBiolife Solutions stock has received a consensus rating of buy. The average rating score is and is based on 8 buy ratings, 0 hold ratings, and 0 sell ratings. What was the 52-week low for Biolife ...

Which BioLife Solutions insiders have been buying company stock? The following insider purchased BLFS shares in the last 24 months: Casdin Partners Master Fund, L ($12,648,274.13). How much insider buying is happening at BioLife Solutions?In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on BioLife Solutions. The company’s shares closed last Thursday at $12.42, close to its 52-week low of $12.11.

BLFS BioLife Solutions, Inc. Earnings Date & History. Follow. $13.250.88 (+7.11%)4:00 PM 12/01/23. NASDAQ | $USD | Post-Market: $13.25 4:55 PM.BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies.BioLife recently disclosed its financial results for the fourth quarter of 2022, showcasing solid revenue growth and a better gross margin. In Q4 2022, the company brought in $44.3 million in ...Todd Berard, BioLife's Chief Marketing Officer, commented, "With a capacity that's 40% larger than other tabletop CRFs, IntelliRate i67C is perfectly sized to efficiently scale precision rate freezing as a customer's capacity needs grow. We designed the IntelliRate i67C to increase single-batch, LN2 CRF capacity from mid- and late-stage …BOTHELL, Wash., Aug. 9, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that it has entered into a definitive agreement to acquire all remaining outstanding shares of privately held Sexton ...Description. BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted ...Consensus BioLife Solutions, Inc. Equities. BLFS. US09062W2044. Market Closed - Nasdaq. Other stock markets.Nov 8, 2023 · Biolife Solutions releases figures for Q3 on November 9. Wall Street analysts predict losses per share of $0.364. Go here to track Biolife Solutions stock price in real-time ahead of earnings.

BioLife Solutions is a leading supplier of class-defining cell and gene therapy bioproduction tools and services. Our tools portfolio includes our proprietary CryoStor® freeze media and ...

Discover historical prices for BLFS stock on Yahoo Finance. View daily, weekly or monthly format back to when BioLife Solutions, Inc. stock was issued.

The current BioLife Solutions [ BLFS] share price is $13.57. The Score for BLFS is 44, which is 12% below its historic median score of 50, and infers higher risk than normal. BLFS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.BioLife Solutions Trading Down 0.4 %. Shares of NASDAQ BLFS traded down $0.06 during mid-day trading on Thursday, hitting $13.57. The stock had a trading volume of 293,613 shares, compared to its ...BioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to de-risk biologic manufacturing, storage, distribution, and transportation in the cell and gene therapy (CGT) industry and broader biopharma markets.Biolife Solutions stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... Do the numbers hold clues to what lies ahead for the stock? BLFS: 20.37 (-0.97%) APYX: 5.06 (+1.81%) BioLife Solutions Reports First Quarter 2023 Financial Results PR Newswire - Wed May 10, 3:03PM CDTBioLife Solutions, Inc. (NASDAQ:BLFS – Get Free Report) shares fell 4.2% during trading on Monday . The company traded as low as $13.37 and last traded at $13.49. 76,840 shares changed hands ...22 mar 2021 ... BioLife expects the acquisition of Stirling to impact the Company's financial performance as follows: 2021 revenue contribution is expected to ...When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll want to ensure that you find the best one available in stock.Nov 8, 2023 · Biolife Solutions stock has received a consensus rating of buy. The average rating score is and is based on 8 buy ratings, 0 hold ratings, and 0 sell ratings. What was the 52-week low for Biolife ... This is a signal that BLFS's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...BioLife Solutions (BLFS) In a report released today, Robert Wasserman from Benchmark Co. maintained a Hold rating on BioLife Solutions. The company’s shares closed last Thursday at $11.96.

BioLife Solutions Stock Price, News & Analysis (NASDAQ:BLFS) $12.51 -0.24 (-1.88%) (As of 05:28 PM ET) Compare Today's Range $12.46 $13.62 50-Day Range $8.99 …BOTHELL, Wash., Jan. 10, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy (CGT) and broader biopharma markets, today announced preliminary revenue for the fourth quarter and full year 2021./PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), ... for $24.0 million, in consideration for 506,382 newly issued shares of BioLife common stock. Taking into ...Instagram:https://instagram. personal loans for retired seniorsworth of 1964 kennedy half dollarhome loan for healthcare workersnasdaq hcsg Dec 1, 2023 · View BioLife Solutions, Inc BLFS investment & stock information. Get the latest BioLife Solutions, Inc BLFS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. The BioLife Solutions stock price gained 3.76% on the last trading day (Friday, 24th Nov 2023), rising from $13.57 to $14.08. During the last trading day the stock fluctuated 11.10% from a day low at $12.79 to a day high of $14.21. The price has risen in 6 of the last 10 days and is up by 23.62% over the past 2 weeks. loser stockbizd BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies.BioLife Solutions Stock Forecast. All Analysts Top Analysts Stock Price Forecast. According to 5 stock analysts, the average 12-month stock price forecast for BLFS stock stock is $26, which predicts an increase of 99.62%. The lowest target is $23 and the highest is $29. On average, analysts rate BLFS stock stock as a strong buy. forex funding programs Biolife Solutions will release earnings for Q1 on May 10. Wall Street predict expect Biolife Solutions will release losses per share of $0.213. Go here to watch Biolife Solutions stock price in ...BioLife Solutions (BLFS) In a report released today, Robert Wasserman from Benchmark Co. maintained a Hold rating on BioLife Solutions. The company’s shares closed last Thursday at $11.96.BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and …